The Core Ultrasound Applications for Nurse Practitioners
September 16, 2025 updated by: National Taiwan University Hospital
The Development and Assessment of the Core Ultrasound Applications for Nurse Practitioners in Taiwan
This project aims to establish point-of-care ultrasound (PoCUS) training course for nurse practitioners in Taiwan, and standardized evaluation modules. The study subjects are nurse practitioners across different hospital levels.
I
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Detailed Description
This project aims to establish point-of-care ultrasound (PoCUS) training course for nurse practitioners in Taiwan, and standardized evaluation modules.
The study subjects are nurse practitioners across different hospital levels.
Study Type
Observational
Enrollment (Estimated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Taiwan
-
Taipei, Taiwan, Taiwan, 100
- Wan-Ching Lien
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
nursing practitioners
Description
Inclusion Criteria:
nursing practitioners who are interested in PoCUS.
Exclusion Criteria:
nursing practitioners who are not interested in PoCUS.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
written test
Time Frame: 1day
|
10 multi-choice questionaire
|
1day
|
|
hands-on performance
Time Frame: 1 day
|
using 5-point Likert scale.
Point 1 indicated no recognizable structures; point 2 indicated minimally recognizable structures but insufficient for diagnosis; point 3 indicated minimal criteria met for diagnosis, recognizable structures but with some technical flaws; point 4 indicated all structures imaged well and diagnosis easily supported; point 5 indicated all structures imaged with excellent image quality and diagnosis completely supported
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
written test at the 3-month assessment
Time Frame: 3 months
|
10 multi-choice questionaire
|
3 months
|
|
hands-on performance at the 3-month assessment
Time Frame: 3 months
|
using 5-point Likert scale.
Point 1 indicated no recognizable structures; point 2 indicated minimally recognizable structures but insufficient for diagnosis; point 3 indicated minimal criteria met for diagnosis, recognizable structures but with some technical flaws; point 4 indicated all structures imaged well and diagnosis easily supported; point 5 indicated all structures imaged with excellent image quality and diagnosis completely supported
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Wan-Ching Lien, NTUH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
July 25, 2024
First Submitted That Met QC Criteria
August 4, 2024
First Posted (Actual)
August 9, 2024
Study Record Updates
Last Update Posted (Actual)
September 22, 2025
Last Update Submitted That Met QC Criteria
September 16, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 202112120RINB
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.